$CRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Get notifications about new insider transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 63 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.32 | 2,128 | 598,652 | 255,041 | 257.2 K to 255 K (-0.83 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 18,200 | 22.9 K to 18.2 K (-20.55 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 18,200 | 22.9 K to 18.2 K (-20.55 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 11,862 | 0 | 22,908 | 11 K to 22.9 K (+107.39 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 11,862 | 0 | 22,908 | 11 K to 22.9 K (+107.39 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Gift | G | 0.00 | 310 | 0 | 11,046 | 11.4 K to 11 K (-2.73 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Gift | G | 0.00 | 310 | 0 | 11,046 | 11.4 K to 11 K (-2.73 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 259.05 | 251 | 65,022 | 5,628 | 5.9 K to 5.6 K (-4.27 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 259.05 | 251 | 65,022 | 5,628 | 5.9 K to 5.6 K (-4.27 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 260.88 | 953 | 248,619 | 4,608 | 5.6 K to 4.6 K (-17.14 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Grant | A | 0.00 | 3,162 | 0 | 5,561 | 2.4 K to 5.6 K (+131.80 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 260.88 | 4,709 | 1,228,484 | 30,005 | 34.7 K to 30 K (-13.57 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Grant | A | 0.00 | 11,862 | 0 | 34,714 | 22.9 K to 34.7 K (+51.91 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 260.88 | 32,753 | 8,544,603 | 257,169 | 289.9 K to 257.2 K (-11.30 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Grant | A | 0.00 | 75,129 | 0 | 289,922 | 214.8 K to 289.9 K (+34.98 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 3,500 | 0 | 214,793 | 218.3 K to 214.8 K (-1.60 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 4,706 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 260.88 | 3,795 | 990,040 | 17,550 | 21.3 K to 17.6 K (-17.78 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 14,234 | 0 | 21,345 | 7.1 K to 21.3 K (+200.17 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 8,656 | 0 to 8.7 K |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 7,111 | 15.8 K to 7.1 K (-54.90 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 13,053 | 17.8 K to 13.1 K (-26.51 %) |
| Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Grant | A | 0.00 | 11,862 | 0 | 17,761 | 5.9 K to 17.8 K (+201.08 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 236.29 | 2,150 | 508,015 | 9,821 | 12 K to 9.8 K (-17.96 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 236.29 | 2,150 | 508,015 | 9,821 | 12 K to 9.8 K (-17.96 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 180 | 0 | 11,971 | 12.2 K to 12 K (-1.48 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 180 | 0 | 11,971 | 12.2 K to 12 K (-1.48 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 12,151 | 0 | 12,151 | 0 to 12.2 K |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 12,151 | 0 | 12,151 | 0 to 12.2 K |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 12,151 | 0 | 5,899 | 18.1 K to 5.9 K (-67.32 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 12,151 | 0 | 5,899 | 18.1 K to 5.9 K (-67.32 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | M | 144.67 | 3,042 | 440,086 | 9,128 | |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | M | 109.34 | 3,205 | 350,435 | 6,409 | |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | M | 88.05 | 492 | 43,321 | 3,493 | |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 251.18 | 3,520 | 884,144 | 11,356 | 14.9 K to 11.4 K (-23.66 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 250.23 | 580 | 145,133 | 14,876 | 15.5 K to 14.9 K (-3.75 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 249.09 | 2,639 | 657,350 | 15,456 | 18.1 K to 15.5 K (-14.58 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Buy | M | 144.67 | 3,042 | 440,086 | 18,095 | 15.1 K to 18.1 K (+20.21 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Buy | M | 109.34 | 3,205 | 350,435 | 15,053 | 11.8 K to 15.1 K (+27.05 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Buy | M | 88.05 | 492 | 43,321 | 11,848 | 11.4 K to 11.8 K (+4.33 %) |
| Nov 05 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Gift | G | 0.00 | 285 | 0 | 11,356 | 11.6 K to 11.4 K (-2.45 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 234.31 | 1,018 | 238,523 | 186,777 | 187.8 K to 186.8 K (-0.54 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 233.74 | 5,206 | 1,216,850 | 187,795 | 193 K to 187.8 K (-2.70 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 232.56 | 1,191 | 276,977 | 193,001 | 194.2 K to 193 K (-0.61 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 231.74 | 14,585 | 3,379,916 | 194,192 | 208.8 K to 194.2 K (-6.99 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 1,000 | 0 | 208,777 | 209.8 K to 208.8 K (-0.48 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 1,000 | 0 | 209,777 | 210.8 K to 209.8 K (-0.47 %) |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | P | 233.24 | 6,050 | 1,411,104 | 6,050 | 0 to 6.1 K |
| Nov 03 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | P | 232.96 | 1,150 | 267,902 | 31,715 | 30.6 K to 31.7 K (+3.76 %) |
| Sep 15 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 220.78 | 70 | 15,455 | 9,441 | 9.5 K to 9.4 K (-0.74 %) |
| Sep 15 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 220.15 | 1,288 | 283,554 | 9,511 | 10.8 K to 9.5 K (-11.93 %) |
| Sep 15 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 219.27 | 585 | 128,275 | 10,799 | 11.4 K to 10.8 K (-5.14 %) |
| Sep 15 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Gift | G | 0.00 | 500 | 0 | 11,384 | 11.9 K to 11.4 K (-4.21 %) |
| Aug 21 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 213.51 | 933 | 199,205 | 22,852 | 23.8 K to 22.9 K (-3.92 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 218.58 | 300 | 65,575 | 37,657 | 38 K to 37.7 K (-0.79 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 217.25 | 700 | 152,076 | 37,957 | 38.7 K to 38 K (-1.81 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Gift | G | 0.00 | 110 | 0 | 38,657 | 38.8 K to 38.7 K (-0.28 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Gift | G | 0.00 | 460 | 0 | 38,767 | 39.2 K to 38.8 K (-1.17 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Gift | G | 0.00 | 155 | 0 | 39,227 | 39.4 K to 39.2 K (-0.39 %) |
| Aug 19 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Gift | G | 0.00 | 900 | 0 | 39,382 | 40.3 K to 39.4 K (-2.23 %) |
| Aug 11 2020 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 216.24 | 2,319 | 501,467 | 6,728 | 9 K to 6.7 K (-25.63 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 217.77 | 19,287 | 4,200,161 | 210,777 | 230.1 K to 210.8 K (-8.38 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 216.34 | 4,713 | 1,019,610 | 230,064 | 234.8 K to 230.1 K (-2.01 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 4,600 | 0 | 234,777 | 239.4 K to 234.8 K (-1.92 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 2,000 | 0 | 239,377 | 241.4 K to 239.4 K (-0.83 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 144.67 | 3,304 | 477,990 | 9,914 | |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 216.82 | 1,007 | 218,334 | 20,767 | 21.8 K to 20.8 K (-4.62 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 216.42 | 2,297 | 497,110 | 21,774 | 24.1 K to 21.8 K (-9.54 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 144.67 | 3,304 | 477,990 | 24,071 | 20.8 K to 24.1 K (+15.91 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Option Exercise | M | 144.67 | 735 | 106,332 | 2,206 | |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Option Exercise | M | 109.34 | 1,709 | 186,862 | 1,710 | |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Option Exercise | M | 90.43 | 997 | 90,159 | 333 | |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Sell | S | 216.93 | 663 | 143,824 | 2,399 | 3.1 K to 2.4 K (-21.65 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Sell | S | 216.52 | 2,793 | 604,732 | 3,062 | 5.9 K to 3.1 K (-47.70 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Buy | M | 144.67 | 735 | 106,332 | 5,855 | 5.1 K to 5.9 K (+14.36 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Buy | M | 109.34 | 1,709 | 186,862 | 5,120 | 3.4 K to 5.1 K (+50.10 %) |
| Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Buy | M | 90.43 | 997 | 90,159 | 3,411 | 2.4 K to 3.4 K (+41.30 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corporate Executive ... | Grant | A | 0.00 | 557 | 0 | 224,478 | 223.9 K to 224.5 K (+0.25 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | A | 179.66 | 38,310 | 6,882,775 | 38,310 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Grant | A | 0.00 | 11,483 | 0 | 241,377 | 229.9 K to 241.4 K (+4.99 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Option Exercise | A | 179.66 | 1,616 | 290,331 | 1,616 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Grant | A | 0.00 | 484 | 0 | 2,414 | 1.9 K to 2.4 K (+25.08 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | A | 179.66 | 7,261 | 1,304,511 | 7,261 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 2,176 | 0 | 20,767 | 18.6 K to 20.8 K (+11.70 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | A | 179.66 | 6,054 | 1,087,662 | 6,054 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Grant | A | 0.00 | 1,815 | 0 | 18,050 | 16.2 K to 18.1 K (+11.18 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | A | 179.66 | 6,500 | 1,167,790 | 6,500 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Grant | A | 0.00 | 1,948 | 0 | 23,785 | 21.8 K to 23.8 K (+8.92 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | A | 179.66 | 6,685 | 1,201,027 | 6,685 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 2,004 | 0 | 11,641 | 9.6 K to 11.6 K (+20.79 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | KUO JOHN W | CEVP General Counse ... | Option Exercise | A | 179.82 | 4,636 | 833,646 | 4,636 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | KUO JOHN W | CEVP General Counse ... | Option Exercise | A | 179.66 | 5,942 | 1,067,540 | 5,942 | |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | KUO JOHN W | CEVP General Counse ... | Grant | A | 0.00 | 1,390 | 0 | 3,171 | 1.8 K to 3.2 K (+78.05 %) |
| Jun 02 2020 | CRL | CHARLES RIVER LABO ... | KUO JOHN W | CEVP General Counse ... | Grant | A | 0.00 | 1,781 | 0 | 1,781 | 0 to 1.8 K |
| May 26 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 174.75 | 83 | 14,504 | 11,884 | 12 K to 11.9 K (-0.69 %) |
| May 26 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 173.87 | 255 | 44,338 | 11,967 | 12.2 K to 12 K (-2.09 %) |
| May 26 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 173.01 | 603 | 104,326 | 12,222 | 12.8 K to 12.2 K (-4.70 %) |
| May 21 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
| May 21 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Sell | S | 174.58 | 3,530 | 616,263 | 29,134 | 32.7 K to 29.1 K (-10.81 %) |
| May 21 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Buy | M | 52.29 | 3,530 | 184,584 | 32,664 | 29.1 K to 32.7 K (+12.12 %) |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | M | 88.05 | 3,000 | 264,150 | 3,985 | |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Option Exercise | M | 73.70 | 3,350 | 246,895 | 0 | |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 174.65 | 350 | 61,128 | 9,637 | 10 K to 9.6 K (-3.50 %) |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 168.81 | 4,899 | 827,002 | 9,987 | 14.9 K to 10 K (-32.91 %) |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Sell | S | 168.00 | 10,519 | 1,767,168 | 14,886 | 25.4 K to 14.9 K (-41.41 %) |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Buy | M | 88.05 | 3,000 | 264,150 | 25,405 | 22.4 K to 25.4 K (+13.39 %) |
| May 19 2020 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Buy | M | 73.70 | 3,350 | 246,895 | 22,405 | 19.1 K to 22.4 K (+17.58 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 164.43 | 1,565 | 257,332 | 249,329 | 250.9 K to 249.3 K (-0.62 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 163.89 | 4,706 | 771,245 | 250,894 | 255.6 K to 250.9 K (-1.84 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 162.73 | 2,025 | 329,528 | 255,600 | 257.6 K to 255.6 K (-0.79 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 161.84 | 5,582 | 903,414 | 257,625 | 263.2 K to 257.6 K (-2.12 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 160.85 | 3,568 | 573,913 | 263,207 | 266.8 K to 263.2 K (-1.34 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Grant | A | 0.00 | 741 | 0 | 40,282 | 39.5 K to 40.3 K (+1.87 %) |
| May 13 2020 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 165.74 | 780 | 129,277 | 21,837 | 22.6 K to 21.8 K (-3.45 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | Andrews Nancy C | Director | Grant | A | 0.00 | 741 | 0 | 865 | 124 to 865 (+597.58 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Grant | A | 0.00 | 518 | 0 | 29,134 | 28.6 K to 29.1 K (+1.81 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Grant | A | 0.00 | 741 | 0 | 28,616 | 27.9 K to 28.6 K (+2.66 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | WILSON VIRGINIA M | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | WILSON VIRGINIA M | Director | Grant | A | 0.00 | 741 | 0 | 1,812 | 1.1 K to 1.8 K (+69.19 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 639 | 0 | 28,417 | 27.8 K to 28.4 K (+2.30 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 741 | 0 | 27,778 | 27 K to 27.8 K (+2.74 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 457 | 0 | 9,025 | 8.6 K to 9 K (+5.33 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MACKAY MARTIN | Director | Grant | A | 0.00 | 741 | 0 | 8,568 | 7.8 K to 8.6 K (+9.47 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 487 | 0 | 62,889 | 62.4 K to 62.9 K (+0.78 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 741 | 0 | 62,402 | 61.7 K to 62.4 K (+1.20 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 457 | 0 | 30,565 | 30.1 K to 30.6 K (+1.52 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 741 | 0 | 30,108 | 29.4 K to 30.1 K (+2.52 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Grant | A | 0.00 | 741 | 0 | 9,047 | 8.3 K to 9 K (+8.92 %) |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
| May 12 2020 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Grant | A | 0.00 | 741 | 0 | 12,825 | 12.1 K to 12.8 K (+6.13 %) |
| May 08 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 150.00 | 1,884 | 282,600 | 18,591 | 20.5 K to 18.6 K (-9.20 %) |
| May 04 2020 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 144.67 | 62 | 8,970 | 1,930 | 2 K to 1.9 K (-3.11 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | M | 144.67 | 2,755 | 398,566 | 8,266 | |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | M | 109.34 | 3,205 | 350,435 | 6,409 | |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | M | 88.05 | 3,492 | 307,471 | 3,493 | |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Option Exercise | M | 73.70 | 3,015 | 222,206 | 0 | |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 164.81 | 5,005 | 824,852 | 16,235 | 21.2 K to 16.2 K (-23.56 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Sell | S | 164.09 | 8,961 | 1,470,448 | 21,240 | 30.2 K to 21.2 K (-29.67 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Buy | M | 144.67 | 2,755 | 398,566 | 30,201 | 27.4 K to 30.2 K (+10.04 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Buy | M | 109.34 | 3,205 | 350,435 | 27,446 | 24.2 K to 27.4 K (+13.22 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Buy | M | 88.05 | 3,492 | 307,471 | 24,241 | 20.7 K to 24.2 K (+16.83 %) |
| Mar 06 2020 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Buy | M | 73.70 | 3,015 | 222,206 | 20,749 | 17.7 K to 20.7 K (+17.00 %) |